HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Guerlain Finds Its Fragrance “Muse” In Actress Hilary Swank

This article was originally published in The Rose Sheet

  • News

Executive Summary

Guerlain has signed Academy Award-winning actress Hilary Swank as a spokesmodel and "muse" for a new women's fragrance slated to launch in the U.S. in September, the LVMH division announced Feb. 20

You may also be interested in...



Guerlain Insolence Fragrance Launch Backed With Print Ads

Guerlain will support the launch of Insolence fragrance for women with print ads featuring actress Hilary Swank

Guerlain Insolence Fragrance Launch Backed With Print Ads

Guerlain will support the launch of Insolence fragrance for women with print ads featuring actress Hilary Swank

Celebrity Fragrances Capture Mass Market Spotlight In 2005 – IRI

Celebrity spokesmodels represent an untapped opportunity for fragrance mass marketers seeking to reinvent or revitalize existing brands, according to IRI Client Solutions representative Leigh Anne Rowinski

Table

View full table

Tags:
Latest Headlines

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

See All
UsernamePublicRestriction

Register

RS013742

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By